Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.

The Position

The Institute of Human Biology (IHB) is a newly established research center in Basel, Switzerland, dedicated to advancing human biology through the use of human model systems for translational research. Our dynamic and interdisciplinary environment fosters collaboration among biologists, engineers, and data scientists, bridging the gap between academic and pharmaceutical research. Closely associated with Roche’s Pharmaceutical Research and Early Development (pRED), we partner with leading academic institutions both locally and globally to address grand challenges with bold, innovative science.

We are excited to announce a search for Junior Group Leaders to establish independent, exploratory research programs at IHB. If you have recently completed a successful postdoctoral appointment and are eager to launch your career as a principal investigator, we encourage you to apply. These roles come with a highly competitive funding package to support your research.

As a Junior Group Leader, you will collaborate with world-class academic institutions such as ETH Zürich and EPFL, as well as global biopharma leaders. You will have access to a wide network of academic and industry experts, state-of-the-art platforms and technologies, and Roche’s core facilities. This collaborative environment will offer you the freedom to conduct innovative research, while shaping your research vision and making meaningful contributions to human biology.

Requirements:

We are looking for the most innovative scientific minds—exceptional individuals with a proven track record of groundbreaking research. We seek those who consistently push the boundaries of discovery, exhibit extraordinary leadership potential, and possess the passion and creativity to drive transformative advances in science. We are particularly interested in candidates who:

• Are passionate about human model system research in areas such as Immunology, Neurology, Ophthalmology, Metabolism, and Oncology.

• Have a deep curiosity about the basic biology of health and disease and are driven to translate discoveries into transformative medicines through collaboration with pRED and other Roche scientists.

This position is fully funded for 5 years, supporting a group size of 4 members plus 1 PI.

Join us at IHB, where your passion and expertise will help shape the future of medicine and make a real difference in people's lives.

IHB Fast Facts:

IHB website: https://institutehumanbiology.com
IHB Director: Hans Clevers
CoDirectors: Marianne Manchester, Matthias Lutolf, Daniele Soroldoni
Planned Size: 250 researchers
IHB platforms and expertise: Single-cell genomics, Microtechnologies, bioengineering, High-throughput imaging, CRISPR-gene editing, Biobanking, Automation, Applied translation support
Core facilities: Fluorescent microscopy, Genomics and high-throughput sequencing, Flow cytometry and cell sorting, Proteomics/Metabolomics, Information technology
PhD program: Department of Biosystems Science and Engineering, ETH Zürich

Questions can be directed to: ihbglobal@roche.com

Application Deadline: 22.11.2024

Application Documents:

• Research statement (2-page summary of previous research, 3-page overview of research vision and plan)

• CV

• Contact information for three references

Basel Hub and the Swiss Landscape

Basel is an international hub for research and innovation. The University of Basel, Department of Biosystems Sciences and Engineering of the ETH Zürich, Friedrich Miescher Institute for Biomedical Research, Swiss Tropical and Public Health Institute, University Hospital Basel, and Institute of Human Biology, nurture training environments for basic science learning and exploration. Together with headquarters and research innovation centers for world-leading pharmaceutical companies and biotechnology startups, the city is a melting pot of research development and commercialization. IHB has also established close links with the outstanding Swiss technical university, École Polytechnique Fédérale de Lausanne (EPFL).

Who we are

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.

Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.

We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

Roche is an Equal Opportunity Employer.